CYP3A4 and hepatocellular carcinoma: Some DEGs with high topological parameters were defined as hub genes, including the oncogene MYC, which can drive hepatocarcinogenesis [46], the therapeutic target CDK4 for targeted therapy of HCC [47], and the metabolic enzyme CYP3A4, which is involved in the abnormal metabolism of HCC [48].